Aditya Birla Sun Life Pharma and Healthcare Fund-Regular - Payout of IDCW

Open Ended Schemes(Equity Scheme - Sectoral/ Thematic)Very High RiskISIN INF209KB1O09

NAV · 06-Jul-2026

₹23.4000

+7.41%

+7.31%

1Y (CAGR)

+7.76%

3Y (CAGR)

+15.32%

5Y (CAGR)

+5.95%

Since inception (CAGR)

+12.84%

NAV history

hover for values

Risk & SIP analytics

Q2 · 3Y in category

Volatility (3y)

14.52%

Downside dev (3y)

12.52%

Max drawdown (3y)

-21.4%

Sharpe (3y)

0.61

SIP XIRR (3y)

+9.65%

SIP XIRR (5y)

+11.45%

Calendar-year returns

2020 +40.8%2021 +11.1%2022 -17.9%2023 +30.0%2024 +26.3%2025 -4.3%

Fund facts

Fund managerDhaval Shah

AUM₹9,503 Cr

Launch date20-Jun-2019

Plan typeOpen Ended · Equity

Min lumpsum1000

Lock-inNone

Volatility16.55

AMCAditya Birla Sun Life AMC Limited

Objective · The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.

scheme documents ↗